129 related articles for article (PubMed ID: 15934302)
1. Renoprotective effect of benazepril on diabetic nephropathy mediated by P42/44MAPK.
Lv Y; Dong J; Niu X; Liu X
J Huazhong Univ Sci Technolog Med Sci; 2005; 25(1):32-5. PubMed ID: 15934302
[TBL] [Abstract][Full Text] [Related]
2. Effects of benazepril on renal function and kidney expression of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in diabetic rats.
Sun SZ; Wang Y; Li Q; Tian YJ; Liu MH; Yu YH
Chin Med J (Engl); 2006 May; 119(10):814-21. PubMed ID: 16732983
[TBL] [Abstract][Full Text] [Related]
3. [Effects of Tangshenling Mixture and benazepril on rats with diabetic nephropathy and its mechanism].
He XL; Li JP; Chen YP; Zhang ZG; Lin WQ; Chen JH
Zhong Xi Yi Jie He Xue Bao; 2006 Jan; 4(1):43-7. PubMed ID: 16409969
[TBL] [Abstract][Full Text] [Related]
4. [Expression of type I transforming growth factor beta receptor in renal cortex in streptozotocin-induced diabetic rats and the regulation of benazepril].
Wu Y; Lin S
Zhonghua Nei Ke Za Zhi; 1999 Jan; 38(1):9-13. PubMed ID: 11798618
[TBL] [Abstract][Full Text] [Related]
5. [Effects of benazepril on apoptosis in the kidney of diabetic rats].
Duan HJ; Zhang YL; Shi YH; Liu F; Li YM
Yao Xue Xue Bao; 2002 Jun; 37(6):409-11. PubMed ID: 12579793
[TBL] [Abstract][Full Text] [Related]
6. Combined therapy of rhein and benazepril on the treatment of diabetic nephropathy in db/db mice.
Jia ZH; Liu ZH; Zheng JM; Zeng CH; Li LS
Exp Clin Endocrinol Diabetes; 2007 Oct; 115(9):571-6. PubMed ID: 17943690
[TBL] [Abstract][Full Text] [Related]
7. [Effects of valsartan, mycophenolate mofetil and their combined application on TRAIL and nuclear factor-kappaB expression in the kidneys of diabetic rats].
Chen B; Zhang Y; Liu G; Guan GJ; Hou XH; Li XG; Liu JL
Zhonghua Yi Xue Za Zhi; 2008 Feb; 88(8):540-5. PubMed ID: 18649770
[TBL] [Abstract][Full Text] [Related]
8. Mycophenolate mofetil ameliorates diabetic nephropathy through epithelial mesenchymal transition in rats.
Xiao X; Wang J; Chang X; Zhen J; Zhou G; Hu Z
Mol Med Rep; 2015 Sep; 12(3):4043-4050. PubMed ID: 26080907
[TBL] [Abstract][Full Text] [Related]
9. Combination of leflunomide and benazepril reduces renal injury of diabetic nephropathy rats and inhibits high-glucose induced cell apoptosis through regulation of NF-κB, TGF-β and TRPC6.
Li H; Wang Y; Zhou Z; Tian F; Yang H; Yan J
Ren Fail; 2019 Nov; 41(1):899-906. PubMed ID: 31552773
[No Abstract] [Full Text] [Related]
10. Angiotensin-converting enzyme (ACE) 2 overexpression ameliorates glomerular injury in a rat model of diabetic nephropathy: a comparison with ACE inhibition.
Liu CX; Hu Q; Wang Y; Zhang W; Ma ZY; Feng JB; Wang R; Wang XP; Dong B; Gao F; Zhang MX; Zhang Y
Mol Med; 2011; 17(1-2):59-69. PubMed ID: 20844835
[TBL] [Abstract][Full Text] [Related]
11. Benazepril affects integrin-linked kinase and smooth muscle α-actin expression in diabetic rat glomerulus and cultured mesangial cells.
Niu H; Nie L; Liu M; Chi Y; Zhang T; Li Y
BMC Nephrol; 2014 Aug; 15():135. PubMed ID: 25142208
[TBL] [Abstract][Full Text] [Related]
12. Superior renoprotective effects of the combination of breviscapine with enalapril and its mechanism in diabetic rats.
Xu XX; Zhang W; Zhang P; Qi XM; Wu YG; Shen JJ
Phytomedicine; 2013 Jul; 20(10):820-7. PubMed ID: 23664882
[TBL] [Abstract][Full Text] [Related]
13. Extracellular superoxide dismutase ameliorates streptozotocin-induced rat diabetic nephropathy via inhibiting the ROS/ERK1/2 signaling.
Kuo CW; Shen CJ; Tung YT; Chen HL; Chen YH; Chang WH; Cheng KC; Yang SH; Chen CM
Life Sci; 2015 Aug; 135():77-86. PubMed ID: 26006040
[TBL] [Abstract][Full Text] [Related]
14. Benazepril, an angiotensin-converting enzyme inhibitor, alleviates renal injury in spontaneously hypertensive rats by inhibiting advanced glycation end-product-mediated pathways.
Liu XP; Pang YJ; Zhu WW; Zhao TT; Zheng M; Wang YB; Sun ZJ; Sun SJ
Clin Exp Pharmacol Physiol; 2009 Mar; 36(3):287-96. PubMed ID: 19018797
[TBL] [Abstract][Full Text] [Related]
15. Effects of benazepril on cardiac fibrosis in STZ-induced diabetic rats.
Li Q; Wang Y; Sun SZ; Tian YJ; Liu MH
Acta Cardiol; 2010 Aug; 65(4):431-9. PubMed ID: 20821936
[TBL] [Abstract][Full Text] [Related]
16. Renal synthesis of urokinase type-plasminogen activator, its receptor, and plasminogen activator inhibitor-1 in diabetic nephropathy in rats: modulation by angiotensin-converting-enzyme inhibitor.
Kenichi M; Masanobu M; Takehiko K; Shoko T; Akira F; Katsushige A; Takashi H; Yoshiyuki O; Shigeru K
J Lab Clin Med; 2004 Aug; 144(2):69-77. PubMed ID: 15322501
[TBL] [Abstract][Full Text] [Related]
17. Protective effect of the angiotensin-converting enzyme inhibitor perindopril on diabetic glomerulopathy in streptozotocin-induced diabetic rats.
Yan L; Yang R; Cheng H; Fu Z; Zhong G; Yan T
Chin Med J (Engl); 1998 Apr; 111(4):306-8. PubMed ID: 10374392
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic Role of Tangshenkang Granule () in Rat Model with Diabetic Nephropathy.
Hu SJ; Shu B; Jin H; Li XF; Mao JR; Ren KJ; Gao L; Yang L; Wu YW; Wang YJ
Chin J Integr Med; 2018 Aug; 24(8):600-605. PubMed ID: 27778266
[TBL] [Abstract][Full Text] [Related]
19. [Effect of selective cyclooxygenase -2 inhibitor on the renal lesion of streptozotocin-induced diabetic rats and its possible mechanism].
Zuo Y; Gu Y; Ma J; Lin S
Zhonghua Yi Xue Za Zhi; 2002 Feb; 82(4):239-43. PubMed ID: 11953170
[TBL] [Abstract][Full Text] [Related]
20. Protective effect of Gui Qi mixture on the progression of diabetic nephropathy in rats.
Zhang YW; Xie D; Chen YX; Zhang HY; Xia ZX
Exp Clin Endocrinol Diabetes; 2006 Nov; 114(10):563-8. PubMed ID: 17177138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
